My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

10.22 -0.30 (-2.85%)

Streaming Delayed Price Updated: 1:47 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

20 21 Next >

Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

October 03, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Are Gene Therapy Stocks The Market's Next Big Winners?

September 25, 2023

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

Via MarketBeat

Topics Artificial Intelligence

Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals ↗

September 23, 2023

Rocket could launch its medicines sooner, but Intellia is aiming for larger markets.

Via The Motley Fool

1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know ↗

September 19, 2023

Good medicines aren't always good business.

Via The Motley Fool

The Latest Analyst Ratings for Intellia Therapeutics ↗

August 29, 2023

Via Benzinga

Barclays Maintains Overweight Rating for Intellia Therapeutics: Here's What You Need To Know ↗

August 07, 2023

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

2 Top Trends to Invest $500 In Right Now ↗

September 18, 2023

Early investors in these trends may reap the rewards over time.

Via The Motley Fool

Cathie Wood Is Buying These 2 Biotech Stocks Hand Over Fist, and Wall Street Thinks They Could Double ↗

September 10, 2023

These businesses could be on the verge of takeoff.

Via The Motley Fool

Cathie Wood Is Buying This Stock Hand Over Fist. Should You? ↗

September 06, 2023

Intellia has declined in the double digits over the past year.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

September 01, 2023

The widely followed growth investor went stock shopping on the final trading day in August.

Via The Motley Fool

Cathie Wood's Ark Invest Increases Palantir Exposure By $10.08M Amid Market Volatility, Offloads Shopify Stock ↗

August 31, 2023

Via Benzinga

Preview: Intellia Therapeutics's Earnings ↗

August 02, 2023

Via Benzinga

The 3 Most Promising Biotech Stocks to Own Now ↗

August 31, 2023

These top biotech stock picks with high and leading growth potential are must-owns for investors looking for high upside potential.

Via InvestorPlace

Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again ↗

August 30, 2023

The famous growth investor has been making some interesting stock moves lately.

Via The Motley Fool

Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares ↗

August 28, 2023

Via Benzinga

Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge ↗

August 24, 2023

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks ↗

August 24, 2023

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 23, 2023

Via The Motley Fool

These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street ↗

August 23, 2023

Is the Street's optimism justified here?

Via The Motley Fool

Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M ↗

August 22, 2023

Via Benzinga

Topics Earnings

Is Regeneron Pharmaceuticals Still a Top Growth Stock? ↗

August 21, 2023

The biotech's focus on innovation could be a boon for shareholders.

Via The Motley Fool

Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions ↗

August 16, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company ↗

August 15, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections ↗

August 14, 2023

Via Benzinga

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 ↗

July 24, 2023

These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 ↗

July 20, 2023

These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector.

Via InvestorPlace

3 Pharma Stocks That AI is Loving in July ↗

July 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Via InvestorPlace

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.